| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $113.8M | -14.0% |
| R&D Expense | $8.4M | -10.2% |
| SG&A Expense | $16.5M | -12.6% |
| Operating Income | -$11.9M | +31.5% |
| Pre-tax Income | -$10.6M | +29.6% |
| Income Tax | $421K | +32.4% |
| Net Income | -$11.0M | +28.4% |
| EPS (Basic) | -$0.57 | +29.6% |
| EPS (Diluted) | -$0.57 |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $50.6M | +347.8% |
| Short-term Investments | $0 | -100.0% |
| Accounts Receivable | $21.6M | -15.8% |
| Inventory | $23.0M | +20.5% |
| Current Assets | $122.6M | +3.2% |
| Total Assets | $155.1M | -10.2% |
| Current Liabilities | $15.9M | -36.4% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$13.2M | -620.6% |
| Capital Expenditures | $7.4M | -30.2% |
| Investing Cash Flow | $52.4M | +456.0% |
| Financing Cash Flow | $110K | -95.3% |
| Free Cash Flow | -$20.6M | -154.1% |
| +29.6% |
| Total Liabilities |
| $16.5M |
| -34.9% |
| Stockholders' Equity | $138.6M | -5.9% |